These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 28644686)
1. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors. Pirog EC Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686 [TBL] [Abstract][Full Text] [Related]
2. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors. Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908 [TBL] [Abstract][Full Text] [Related]
4. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034 [TBL] [Abstract][Full Text] [Related]
5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
6. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin. Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724 [TBL] [Abstract][Full Text] [Related]
7. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500 [TBL] [Abstract][Full Text] [Related]
8. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516 [TBL] [Abstract][Full Text] [Related]
9. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection. Chen R; Qin P; Luo Q; Yang W; Tan X; Cai T; Jiang Q; Chen H Medicine (Baltimore); 2021 Apr; 100(13):e24927. PubMed ID: 33787580 [TBL] [Abstract][Full Text] [Related]
10. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)]. Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374 [TBL] [Abstract][Full Text] [Related]
11. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization. Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678 [TBL] [Abstract][Full Text] [Related]
12. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443 [TBL] [Abstract][Full Text] [Related]
13. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304 [TBL] [Abstract][Full Text] [Related]
14. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas. Kong CS; Beck AH; Longacre TA Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993 [TBL] [Abstract][Full Text] [Related]
15. New developments in endocervical glandular lesions. McCluggage WG Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447 [TBL] [Abstract][Full Text] [Related]
16. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports. Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281 [TBL] [Abstract][Full Text] [Related]
17. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021 [TBL] [Abstract][Full Text] [Related]
18. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study. Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915 [TBL] [Abstract][Full Text] [Related]
19. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
20. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Staebler A; Sherman ME; Zaino RJ; Ronnett BM Am J Surg Pathol; 2002 Aug; 26(8):998-1006. PubMed ID: 12170086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]